Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.810
0.00 (0.00%)
Apr 29, 2026, 3:16 PM HKT
-11.96%
Market Cap 699.52M
Revenue (ttm) 1.93B
Net Income (ttm) 19.24M
Shares Out 863.60M
EPS (ttm) 0.02
PE Ratio 36.40
Forward PE n/a
Dividend 0.05 (6.17%)
Ex-Dividend Date May 23, 2025
Volume 323,000
Average Volume 459,400
Open 0.790
Previous Close 0.810
Day's Range 0.790 - 0.810
52-Week Range 0.500 - 1.000
Beta 0.45
RSI 46.28
Earnings Date May 26, 2026

About HKG:3737

Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China. The company operates through Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It also provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brand names. In addition, the company manufactures and sells food and Chinese herbs; offers detection and testing services; and manages properties. Fu... [Read more]

Sector Healthcare
Founded 1993
Employees 2,284
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 3737
Full Company Profile

Financial Performance

In 2025, HKG:3737's revenue was 1.74 billion, a decrease of -21.55% compared to the previous year's 2.21 billion. Earnings were 17.29 million, a decrease of -81.84%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.